Banjak Marc's Form 4 filing
iBio, Inc. (IBIO) · filed Mar 27, 2026
- Accession no.
- 0001104659-26-036093
- Filed
- Mar 27, 2026
- Trade date
- Mar 26, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $23.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Banjak MarcCIK 0002033869 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | Common Stock | PPurchaseAcquired | +12,500 | $1.64 | +$20,500 | 23,566 | Direct | |
| Mar 26, 2026 | Common Stock | PPurchaseAcquired | +1,434 | $1.76 | +$2,523.84 | 25,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.